1. Home
  2. LPCN vs ZVIA Comparison

LPCN vs ZVIA Comparison

Compare LPCN & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • ZVIA
  • Stock Information
  • Founded
  • LPCN 1997
  • ZVIA 2007
  • Country
  • LPCN United States
  • ZVIA United States
  • Employees
  • LPCN N/A
  • ZVIA N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • LPCN Health Care
  • ZVIA Consumer Staples
  • Exchange
  • LPCN Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • LPCN 16.1M
  • ZVIA 204.8M
  • IPO Year
  • LPCN N/A
  • ZVIA 2021
  • Fundamental
  • Price
  • LPCN $3.10
  • ZVIA $3.18
  • Analyst Decision
  • LPCN Strong Buy
  • ZVIA Hold
  • Analyst Count
  • LPCN 2
  • ZVIA 2
  • Target Price
  • LPCN $9.00
  • ZVIA $3.38
  • AVG Volume (30 Days)
  • LPCN 60.6K
  • ZVIA 1.1M
  • Earning Date
  • LPCN 08-07-2025
  • ZVIA 08-06-2025
  • Dividend Yield
  • LPCN N/A
  • ZVIA N/A
  • EPS Growth
  • LPCN N/A
  • ZVIA N/A
  • EPS
  • LPCN N/A
  • ZVIA N/A
  • Revenue
  • LPCN $3,674,834.00
  • ZVIA $154,273,000.00
  • Revenue This Year
  • LPCN N/A
  • ZVIA $5.66
  • Revenue Next Year
  • LPCN N/A
  • ZVIA $6.76
  • P/E Ratio
  • LPCN N/A
  • ZVIA N/A
  • Revenue Growth
  • LPCN N/A
  • ZVIA N/A
  • 52 Week Low
  • LPCN $2.68
  • ZVIA $0.62
  • 52 Week High
  • LPCN $8.23
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 43.66
  • ZVIA 53.67
  • Support Level
  • LPCN $3.13
  • ZVIA $3.00
  • Resistance Level
  • LPCN $3.23
  • ZVIA $3.23
  • Average True Range (ATR)
  • LPCN 0.17
  • ZVIA 0.26
  • MACD
  • LPCN -0.01
  • ZVIA -0.02
  • Stochastic Oscillator
  • LPCN 15.69
  • ZVIA 45.92

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: